New Data From Multi-Year Study of Pregnancy Loss Support Efficacy and Diagnostic Power of CombiMatrix’s Chromosomal Microarray Analysis
January 06, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis...
CombiMatrix Announces Multicycle Offering for Pre-Implantation Genetic Screening and Improved Cost Efficiencies
December 16, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 16, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
CombiMatrix Highlights Two Recent Developments
December 11, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 11, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis...
CombiMatrix's Array for Pre-Implantation Genetic Screening Granted Conditional Approval From New York State Department of Health
December 10, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 10, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis...
CombiMatrix Corporation Reports Third Quarter 2015 Financial and Operating Results
November 04, 2015 16:05 ET
|
CombiMatrix Corporation
Growth in Revenue and Test Volumes Driven by Miscarriage Analysis and Pre-implantation Genetic Screening; Reports Narrowed Net Loss and Strong Cash Collections
Conference Call Begins Today at 4:30...
CombiMatrix Corporation to Release Third Quarter Financial Results on November 4, 2015
October 28, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the quarter ended September 30, 2015 after market close on...
New Data From CombiMatrix Study Support Follow-Up Diagnostic Testing to Confirm Positive Results From Non-Invasive Prenatal Testing
October 09, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 9, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix to Present at Upcoming Investment Conferences
September 22, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Sept. 22, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix to Present at Rodman & Renshaw Global Investment Conference
September 02, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix's CombiSNP Array for Prenatal Diagnosis Test Granted Approval From New York State Department of Health
August 18, 2015 07:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Aug. 18, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...